Table 1.
Baseline characteristics of group.
| Variables | (n: 32) | Variables | (n: 32) |
|---|---|---|---|
| Patients characteristics | Laboratory | ||
| Age | 58±9 (40–74) | Creatinin mg/dl | 0.8±0.2 |
| Female/Male | 6/26 | e-GFR ml/min | 100±22 |
| Bmi kg/m2 | 29.2±0.4 | LDL mg/dl | 136±40 |
| Diabetes % | 15/32 | HDL mh/dl | 44±8 |
| Hypertension % | 13/32 | Hb gr/dl | 14±1.7 |
| Hyperlipidemia % | 7/32 | Wbc ×103 | 8.3±2.4 |
| Smoking | 18/32 | Neutrophil ×103 | 5.2±1.8 |
| Admission medication | Lymphocyte ×103 | 2.3±0.8 | |
| Aspirin % | 14/32 | Monocyte ×103 | 0.7±0.3 |
| Beta blocker % | 9/32 | Platelet ×103 | 221±81 |
| Digitals | 0/32 | ||
| Ace/ARB % | 9/32 | ||
| Statin % | 6/32 | ||
| Diuretics % | 0/32 | ||
| Clopidogrel % | 0/32 | ||
| CaCB % | 2/32 |
ACE – angiotensin converting enzyme; ARB – angiotensin reseptor blocker; BMI – body mass index; e-GFR – estimated glomerular filtration rate; NLR – neutrophil to lymphocyte ratio; CaCB – Ca channel blocker; MLR – monocyte to lymphocyte ratio; Wbc – white blood cell. Results are expressed as mean ±SD or frequency (with in group percentage) and median (Interquartile range).